| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |